These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38342499)

  • 1. Comparison of agranulocytosis and anti-neutrophil cytoplasmic antibody-associated vasculitis caused by two antithyroid drugs: A pharmacovigilance study using the WHO international database.
    Han JY; Lee JM; Jung SY; Kim MS; Lee SW; Kronbichler A; Tizaoui K; Koyanagi A; Kim EY; Song K; Chae HW; Yon DK; Shin JI; Smith L
    Fundam Clin Pharmacol; 2024 Aug; 38(4):780-788. PubMed ID: 38342499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Disproportionality Analysis of the Adverse Effect Profiles of Methimazole and Propylthiouracil in Patients with Hyperthyroidism Using the Japanese Adverse Drug Event Report Database.
    Arai M; Tsuno T; Konishi H; Nishiyama K; Terauchi Y; Inoue R; Shirakawa J
    Thyroid; 2023 Jul; 33(7):804-816. PubMed ID: 37130038
    [No Abstract]   [Full Text] [Related]  

  • 3. The onset of antineutrophil cytoplasmic antibody-associated vasculitis immediately after methimazole was switched to propylthiouracil in a woman with Graves' disease who wished to become pregnant.
    Kimura M; Seki T; Ozawa H; Ishihara T; Komatsu M; Tajiri S; Yanagi H; Nishina M; Noh JY; Fukagawa M; Takagi A
    Endocr J; 2013; 60(3):383-8. PubMed ID: 23154533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-dependent incidence of agranulocytosis in patients treated with methimazole and propylthiouracil.
    Yoshimura Noh J; Inoue K; Suzuki N; Yoshihara A; Fukushita M; Matsumoto M; Imai H; Hiruma S; Ichikawa M; Koshibu M; Sankoda A; Hirose R; Watanabe N; Sugino K; Ito K
    Endocr J; 2024 Jul; 71(7):695-703. PubMed ID: 38710619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis mimicking Kawasaki disease.
    Aoki Y; Kitazawa K; Kobayashi H
    Paediatr Int Child Health; 2019 May; 39(2):142-145. PubMed ID: 29457989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro immunoreactivity to propylthiouracil, methimazole, and carbimazole in patients with Graves' disease: a possible cause of antithyroid drug-induced agranulocytosis.
    Wall JR; Fang SL; Kuroki T; Ingbar SH; Braverman LE
    J Clin Endocrinol Metab; 1984 May; 58(5):868-72. PubMed ID: 6200492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful Re-administration of Low-dose of Methimazole (MMI) in Graves' Disease Patients Who Experienced Allergic Cutaneous Reactions to MMI at Initial Treatment and Had Received Long-term Propylthiouracil (PTU).
    Kubota S
    Intern Med; 2016; 55(22):3235-3237. PubMed ID: 27853063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitope analysis of anti-myeloperoxidase antibodies in propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis.
    Wang C; Gou SJ; Xu PC; Zhao MH; Chen M
    Arthritis Res Ther; 2013; 15(6):R196. PubMed ID: 24252385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propylthiouracil-induced antineutrophil cytoplasmic antibody (ANCA)-associated renal vasculitis versus primary ANCA-associated renal vasculitis: a comparative study.
    Chen YX; Zhang W; Chen XN; Yu HJ; Ni LY; Xu J; Pan XX; Ren H; Chen N
    J Rheumatol; 2012 Mar; 39(3):558-63. PubMed ID: 22247359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease.
    Sera N; Ashizawa K; Ando T; Abe Y; Ide A; Usa T; Tominaga T; Ejima E; Yokoyama N; Eguchi K
    Thyroid; 2000 Jul; 10(7):595-9. PubMed ID: 10958312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of agranulocytosis as an adverse effect of antithyroid drugs in the second or later course of treatment.
    Kobayashi S; Noh JY; Mukasa K; Kunii Y; Watanabe N; Matsumoto M; Ohye H; Suzuki M; Yoshihara A; Iwaku K; Sugino K; Ito K
    Thyroid; 2014 May; 24(5):796-801. PubMed ID: 24341564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Characteristics and Outcomes of Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Patients with Graves' Disease: A Median 38-Month Retrospective Cohort Study from a Single Institution in China.
    Yang J; Yao LP; Dong MJ; Xu Q; Zhang J; Weng WW; Chen F
    Thyroid; 2017 Dec; 27(12):1469-1474. PubMed ID: 29088997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTU-induced ANCA-positive vasculitis: an innocent or a life-threatening adverse effect?
    Bilge NS; Kaşifoğlu T; Korkmaz C
    Rheumatol Int; 2013 Jan; 33(1):117-20. PubMed ID: 22228488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antineutrophil cytoplasmic antibody associated vasculitis induced by antithyroid agents].
    Guo XH; Zhao MH; Gao Y; Wang SF; Gao Y
    Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):932-5. PubMed ID: 12899790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of perinuclear antineutrophil cytoplasmic antibody in patients with Graves' disease treated with propylthiouracil or methimazole in Taiwan.
    Huang CN; Hsu TC; Chou HH; Tsay GJ
    J Formos Med Assoc; 2004 Apr; 103(4):274-9. PubMed ID: 15175822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antineutrophil Cytoplasmic Antibody-Positive Small-Vessel Vasculitis Associated with Antithyroid Drug Therapy: How Significant Is the Clinical Problem?
    Balavoine AS; Glinoer D; Dubucquoi S; Wémeau JL
    Thyroid; 2015 Dec; 25(12):1273-81. PubMed ID: 26414658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithyroid drug-related hepatotoxicity in hyperthyroidism patients: a population-based cohort study.
    Wang MT; Lee WJ; Huang TY; Chu CL; Hsieh CH
    Br J Clin Pharmacol; 2014 Sep; 78(3):619-29. PubMed ID: 25279406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes of patients with propylthiouracil-induced anti-neutrophil cytoplasmic auto-antibody-associated vasculitis.
    Gao Y; Chen M; Ye H; Yu F; Guo XH; Zhao MH
    Rheumatology (Oxford); 2008 Oct; 47(10):1515-20. PubMed ID: 18676500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The occurrence of agranulocytosis due to antithyroid drugs in a cohort of patients with Graves disease treated with radioactive iodine 131I during 14 years].
    Cepková J; Gabalec F; Svilias I; Horáček J
    Vnitr Lek; 2014 Oct; 60(10):832-6. PubMed ID: 25382005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety of methimazole and propylthiouracil in pregnancy: a systematic review.
    Hackmon R; Blichowski M; Koren G
    J Obstet Gynaecol Can; 2012 Nov; 34(11):1077-1086. PubMed ID: 23231846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.